Zetidoline, A New Antipsychotic
1984 ◽
Vol 145
(3)
◽
pp. 294-299
◽
Keyword(s):
SummaryZetidoline (ZTD), a compound chemically unrelated to any available antipsychotic, with selective dopamine receptor-blocking properties, was compared with haloperidol (HLP) in a double-blind study on 56 in-patients who had either first episodes or acute relapses of schizophrenia. ZTD was found to be safe, as effective as HLP, and to produce significantly fewer extrapyramidal side-effects (EPS).
2017 ◽
Vol 4
(1)
◽
pp. 45
Keyword(s):
1985 ◽
Vol 147
(3)
◽
pp. 306-309
◽
Keyword(s):
1981 ◽
Vol 9
(3)
◽
pp. 199-202
◽
Keyword(s):
1968 ◽
Vol 20
(03/04)
◽
pp. 583-587
◽
Keyword(s):
Keyword(s):
1963 ◽
Vol 109
(460)
◽
pp. 418-421
◽
Keyword(s):
1987 ◽
Vol 15
(3)
◽
pp. 154-159
◽
1976 ◽
Vol 16
(5-6)
◽
pp. 276-283
◽
Keyword(s):